Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 9OTHER 7FED 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 33Prostatic Neoplasms 26Neoplasms 22Colonic Neoplasms 12Lung Neoplasms 10Colonic Polyps 10Breast Neoplasms 10Rare Diseases 8Adenoma 6Pulmonary Disease, Chronic Obstructive 5Heart Failure 5Rectal Neoplasms 4Ovarian Neoplasms 4Pain 3Mental Disorders 3Death 3Adenomatous Polyps 3Uterine Cervical Neoplasms 2Urinary Incontinence 2Smoking Cessation 2Skin Neoplasms 2Sezary Syndrome 2Respiratory Aspiration 2Renal Insufficiency, Chronic 2Polycystic Ovary Syndrome 2Patient Preference 2Patient Compliance 2Obesity 2Neurologic Manifestations 2Neurofibromatosis 2 2

Interventions

Prednisone 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × FED × Respiratory Tract Diseases × Clear all
NCT00004436 2015-03-25

Randomized Study of Hormonal Regulation of Infantile Hemangioma

FDA Office of Orphan Products Development

Phase NA Completed
30 enrolled

Hemangioma, Respiratory Tract Diseases, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡